Mechanistic Implications of GSK and CREB Crosstalk in Ischemia Injury
- 13 December 2023
- journal article
- review article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 42 (1) , 1-16
Abstract
Ischemia-reperfusion (IR) injury is a damage to an organ when the blood supply is less than the demand required for normal functioning, leading to exacerbation of cellular dysfunction and death. IR injury occurs in different organs like the kidney, liver, heart, brain, etc., and may not only involve the ischemic organ but also cause systemic damage to distant organs. Oxygen-glucose deprivation in cells causes oxidative stress, calcium overloading, inflammation, and apoptosis. CREB is an essential integrator of the body’s various physiological systems, and it is widely accepted that dysfunction of CREB signaling is involved in many diseases, including ischemia-reperfusion injury. The activation of CREB can provide life to a cell and increase the cell’s survival after ischemia. Hence, GSK/CREB signaling pathway can provide significant protection to cells of different organs after ischemia and emerges as a futuristic strategy for managing ischemia-reperfusion injury. Different signaling pathways such as MAPK/ERK, TLR4/MyD88, RISK, Nrf2, and NF-κB, get altered during IR injury by the modulation of GSK-3 and CREB (cyclic AMP response element (CRE)–binding protein). GSK-3 (protein kinase B) and CREB are the downstream targets for fulfilling the roles of various signaling pathways. Calcium overloading during ischemia increases the expression of calcium-calmodulin-dependent protein kinase (CaMK), which subsequently activates CREB-mediated transcription, thus promoting the survival of cells. Furthermore, this review highlights the crosstalk between GSK-3 and CREB, promoting survival and rendering the cells resistant to subsequent severe ischemia.Keywords
This publication has 109 references indexed in Scilit:
- Low Molecular Weight Fucoidan against Renal Ischemia–Reperfusion Injury via Inhibition of the MAPK Signaling PathwayPLOS ONE, 2013
- Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterizationDARU Journal of Pharmaceutical Sciences, 2013
- GSK-3: A Bifunctional Role in Cell Death PathwaysInternational Journal of Cell Biology, 2012
- Phosphorylation of GSK-3β Mediates Intralipid-induced Cardioprotection against Ischemia/Reperfusion InjuryAnesthesiology, 2011
- GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic StrokeFrontiers in Molecular Neuroscience, 2011
- Inhibition of GSK-3β Decreases the Ischemia-Induced Death of Renal CellsBulletin of Experimental Biology and Medicine, 2010
- Involvement of cyclic adenosine diphosphoribose receptor activation in ischemic preconditioning induced protection in mouse brainBrain Research, 2010
- Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3β activation☆Cardiovascular Research, 2007
- Isoflurane Postconditioning Prevents Opening of the Mitochondrial Permeability Transition Pore through Inhibition of Glycogen Synthase Kinase 3βAnesthesiology, 2005
- Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005